Pasithea Therapeutics Corp. Gains 117.39%
Wed, Nov 26, 2025 at 07:46 PM
Pasithea Therapeutics Corp. (KTTA:NASDAQ) shot up at $1.06, a gain of 117.4%. On Wed, Nov 26, 2025, KTTA:NASDAQ touched a New 2-Week High of $1.06. The stock got featured on our News Catalysts scanner on Tue, Nov 25, 2025 at 08:56 AM in the 'BIOTECH' category. From Thu, Nov 13, 2025, the stock recorded 55.56% Up Days and 30.00% Green Days
The stock spiked on Wed, Nov 26, 2025 at $1.34 with a volume of 145M+.
About Pasithea Therapeutics Corp. (KTTA:NASDAQ)
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the research and discovery of new and effective treatments for psychiatric and neurological disorders.
Top 10 Gainers:
- SMX (Security Matters) Public Limited Company (SMX:NASDAQ), 194.42%
- Pasithea Therapeutics Corp. (KTTA:NASDAQ), 117.39%
- Amber International Holding Limited (AMBR:NASDAQ), 56.33%
- KALA BIO, Inc. (KALA:NASDAQ), 42.63%
- Quantum BioPharma Ltd. (QNTM:NASDAQ), 41.92%
- Mobile-health Network Solutions (MNDR:NASDAQ), 39.47%
- Verrica Pharmaceuticals Inc. (VRCA:NASDAQ), 31.05%
- K Wave Media Ltd. (KWM:NASDAQ), 29.59%
- Boqii Holding Limited (BQ:NYSEMKT), 29.55%
- Quince Therapeutics, Inc. (QNCX:NASDAQ), 29.21%